5-Nitro-1H-indazole-3-carbonitrile (DL0805) is aRho kinase(ROCK)inhibitor with anIC50of 6.67 μM for ROCK-I. 5-Nitro-1H-indazole-3-carbonitrile reducesNorepinephrine-induced transient contraction and inhibits contraction induced by increasing external calcium in the endothelium-denuded rings of rat models. 5-Nitro-1H-indazole-3-carbonitrile has a vasorelaxant activity but high toxicity. 5-Nitro-1H-indazole-3-carbonitrile can be used for cardiovascular diseases, especially hypertension research[1][2].
References:
[1].Yuan TY, et al. DL0805-2, a novel indazole derivative, relaxes angiotensin II-induced contractions of rat aortic rings by inhibiting Rho kinase and calcium fluxes. Acta Pharmacol Sin. 2016 May;37(5):604-16.
















